14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of TRVI
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Friday for Trevi Therapeutics Inc.
(Updated on May 03, 2024)

Sell candidate since Apr 09, 2024 Gain 4.86% PDF

The Trevi Therapeutics Inc. stock price gained 0.332% on the last trading day (Friday, 3rd May 2024), rising from $3.01 to $3.02. During the last trading day the stock fluctuated 4.70% from a day low at $2.98 to a day high of $3.12. The price has been going up and down for this period, and there has been a 6.53% gain for the last 2 weeks. Volume fell on the last day by -59 thousand shares and in total, 25 thousand shares were bought and sold for approximately $76.32 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 28.68% during the next 3 months and, with a 90% probability hold a price between $2.99 and $5.34 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

TRVI Signals & Forecast

There are mixed signals in the stock today. The Trevi Therapeutics Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $3.06. On a fall, the stock will find some support from the short-term average at $2.87. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Thursday, March 21, 2024, and so far it has fallen -18.38%. Further fall is indicated until a new bottom pivot has been found. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Trevi Therapeutics Inc. stock

Trevi Therapeutics Inc. finds support from accumulated volume at $2.93 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.140 between high and low, or 4.70%. For the last week the stock has had daily average volatility of 6.95%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (TRVI) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect Trevi Therapeutics Inc. to open at $3.04, and during the day (based on 14 day Average True Range), to move between $2.77 and $3.27, which gives a possible trading interval of +/-$0.251 (+/-8.31%) up or down from last closing price. If Trevi Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 16.63% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $3.07 (1.66%) than the support at $2.93 (2.98%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Earnings coming up

Trevi Therapeutics Inc. will release earnings AMC on Thursday, May 09, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.0900. We will update the financials statements for Trevi Therapeutics Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 9.36% in the first trading day after earnings release.

Is Trevi Therapeutics Inc. stock A Buy?

Trevi Therapeutics Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.728 Sell Candidate Unchanged

Predicted Opening Price for Trevi Therapeutics Inc. of Monday, May 6, 2024

Fair opening price May 6, 2024 Current price
$3.04 ( 0.662%) $3.02

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for TRVI

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.18 5.30 %
R2 3.13 3.53 %
R1 3.09 2.43 %
Current price: 3.02
Support S1 2.99 -1.11 %
S2 2.95 -2.20 %
S3 2.90 -3.97 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.36 11.26 %
R2 3.35 10.93 %
R1 3.07 1.66 %
Current price 3.02
Support S1 2.93 -2.98%
S2 2.73 -9.60%
S3 2.38 -21.19%

FAQ

What is the symbol for Trevi Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Trevi Therapeutics Inc. is TRVI and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Trevi Therapeutics Inc. Stock?
Trevi Therapeutics Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Trevi Therapeutics Inc. Stock?
Trevi Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Trevi Therapeutics Inc. Stock.

What's the current price of Trevi Therapeutics Inc. Stock?
As of the end of day on the May 03, 2024, the price of an Trevi Therapeutics Inc. (TRVI) share was $3.02.

What is the 52-week high and low for Trevi Therapeutics Inc. Stock?
The 52-week high for Trevi Therapeutics Inc. Stock is $251.33 and the 52-week low is $140.40.

What is the market capitalization of Trevi Therapeutics Inc. Stock?
As of the May 03, 2024, the market capitalization of Trevi Therapeutics Inc. is 208.26M.

When is the next earnings date for Trevi Therapeutics Inc.?
The upcoming earnings date for Trevi Therapeutics Inc. is May 09, 2024.
Click to get the best stock tips daily for free!

About Trevi Therapeutics Inc.

Trevi Therapeutics. Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis. It has a license agreement with Endo P... TRVI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT